Oxford Biomedica plc (OTCMKTS:OXBDF – Get Free Report) fell 3.3% during trading on Thursday . The company traded as low as $4.95 and last traded at $4.95. 200 shares changed hands during mid-day trading, an increase of 84% from the average session volume of 109 shares. The stock had previously closed at $5.12.
Oxford Biomedica Stock Performance
The company’s 50 day moving average price is $5.27 and its two-hundred day moving average price is $4.87. The company has a debt-to-equity ratio of 1.48, a current ratio of 2.35 and a quick ratio of 2.07.
Oxford Biomedica Company Profile
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Featured Stories
- Five stocks we like better than Oxford Biomedica
- What is the NASDAQ Stock Exchange?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- How to Use High Beta Stocks to Maximize Your Investing Profits
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- When to Sell a Stock for Profit or Loss
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.
